Treatment-Experienced Genotype 3

Page Retired 1/21/2021

The following pages include guidance for management of treatment-experienced patients with genotype 3 infection.

• Peginterferon/Ribavirin-Experienced, Genotype 3 Patients Without Cirrhosis
• Peginterferon/Ribavirin-Experienced, Genotype 3 Patients With Compensated Cirrhosis
• DAA-Experienced (Including NS5A Inhibitors Except Glecaprevir/Pibrentasvir Failures), Genotype 3 Patients, With or Without Compensated Cirrhosis
• Glecaprevir/Pibrentasvir Treatment Failures (All Genotypes)
• Sofosbuvir/Velpatasvir/Voxilaprevir Treatment Failure (All Genotypes)